DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents Accepting Nominations for New Scientific/Clinical Members
The Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is accepting nominations for new scientific/clinical members with expertise in HIV medicine. The Panel is particularly, though not exclusively, seeking candidates with expertise in (1) HIV-related biostatistics or (2) HIV and women’s health issues (including issues related to HIV and pregnancy). Panel members critically evaluate new information and prepare guidelines revisions. The candidates shall be recognized experts in their areas of interest with outstanding records of publications and presentations. The successful candidates shall serve a 4-year term beginning February 2011, with potential for reappointment for an additional term.
The Panel is a Working Group of the Office of AIDS Research Advisory Council of the National Institutes of Health. The Panel is comprised of approximately 30 members who are clinicians, researchers, academicians, DHHS representatives, and community representatives with expertise in HIV management in the United States. The Panel meets monthly via teleconference and annually in a face-to-face meeting to review and critically evaluate emerging scientific data relating to antiretroviral therapy and revise the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. The latest guidelines were published on December 1, 2009, and can be found at the AIDSinfo Web site.
Panel members are not compensated for their time commitment, and travel support is generally not provided.
The nomination should include a curriculum vitae and a letter of nomination or letter of interest with specific reference to how the nominee would contribute to the work of the Panel. Please submit nominations to Alice Pau, Pharm.D. at the following address no later than October 22, 2010:
Alice K. Pau, Pharm.D.
Executive Secretary, Division of Clinical Research
NIAID-NIH, Bldg 10, Rm 11C103
Bethesda, MD 20892
or e-mail: firstname.lastname@example.org
Join AIDSinfo in Observing National Gay Men’s HIV/AIDS Awareness Day
September 27 marks the third annual observance of National Gay Men’s HIV/AIDS Awareness Day, a day that serves to increase awareness of HIV/AIDS in the gay community. According to the 2008 surveillance data from the Centers for Disease Control and Prevention (CDC), the estimated number of men who have sex with men receiving an HIV or AIDS diagnosis has been increasing over the past several years, indicating that HIV continues to take a heavy toll on this community.
AIDSinfo has developed a specialty page for this awareness day with information and resources about HIV/AIDS and gay men.
More information is available:
NIH Research to Focus on Effective Ways to Prevent and Treat HIV/AIDS in Inmates
“Twelve scientific teams in more than a dozen states will receive National Institutes of Health grants to study effective ways to prevent and treat HIV/AIDS among people in the criminal justice system. The grants, announced today, will be awarded primarily by the National Institute on Drug Abuse (NIDA), with additional support from the National Institute of Mental Health (NIMH) and the National Institute of Allergy and Infectious Diseases (NIAID), all components of NIH. …
"‘These important and wide reaching research grants will focus on identifying individuals with HIV within the criminal justice system and linking them to highly active antiretroviral therapy (HAART) during periods of incarceration and after community re-entry,’ said NIDA Director Dr. Nora D. Volkow. ‘We hope this effort will lead to decreased HIV/AIDS-related illness and death among those in the criminal justice system, as well as decrease HIV transmission in the community at-large, making an important impact on public health.’ …
“The funding opportunity, Seek, Test, and Treat: Addressing HIV in the Criminal Justice System, represents NIH’s largest research initiative to date to aggressively identify and treat HIV-positive inmates, parolees and probationers and to help them continue care when they return to their communities. Close to $50 million dollars in grants over a five-year period are expected under this research initiative.”
More information is available: